GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $48,711,000 | +15.3% | 1,117,014 | +15.2% | 0.10% | +35.6% |
| Q1 2022 | $42,243,000 | +22.4% | 969,278 | +23.9% | 0.07% | +32.7% |
| Q4 2021 | $34,507,000 | +34.7% | 782,501 | +16.7% | 0.06% | +27.9% |
| Q3 2021 | $25,618,000 | +7.0% | 670,469 | +11.5% | 0.04% | +7.5% |
| Q2 2021 | $23,949,000 | +40.7% | 601,469 | +26.6% | 0.04% | +33.3% |
| Q1 2021 | $17,018,000 | +24.6% | 475,027 | +28.0% | 0.03% | +11.1% |
| Q4 2020 | $13,663,000 | +4183.1% | 370,979 | +5355.6% | 0.03% | +2600.0% |
| Q4 2019 | $319,000 | -86.8% | 6,800 | -88.2% | 0.00% | -75.0% |
| Q1 2019 | $2,413,000 | +9.3% | 57,748 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $2,207,000 | +406.2% | 57,748 | +432.3% | 0.01% | +400.0% |
| Q3 2018 | $436,000 | -92.2% | 10,848 | -93.1% | 0.00% | -88.9% |
| Q4 2017 | $5,610,000 | +870.6% | 158,014 | +1053.4% | 0.01% | +800.0% |
| Q1 2017 | $578,000 | – | 13,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |